As a result of the coronavirus pandemic, many leading stocks have suffered significant falls in 2020. Investors looking for promising stock may consider the current Barclays share price to be a good investing opportunity. Barclays Bank PLC (LON: BARC) is one of the UK’s “Big Four” banks and part of the FTSE 100.
Range of stock exchanges
Since the stock market crash that started in February 2020, Barclays's share price has had significant positive movement.
Its last market close was 182.72p, which is 1.70% up on its pre-crash value of 179.62p and 150.16% up on the lowest point reached during the March 2020 crash when the shares fell as low as 73.04p.
If you had bought £1,000 worth of Barclays shares at the start of February 2020, those shares would have been worth £499.17 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,076.84.
|52-week range||88.885p - 190.5596p|
|50-day moving average||182.2606p|
|200-day moving average||179.2729p|
|Wall St. target price||221.84p|
|Dividend yield||3p (1.64%)|
|Earnings per share (TTM)||26.3p|
Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
|Platform||Platform fee||Min. initial deposit||Trading fee estimate|
|Capital at risk|
|Capital at risk|
|Capital at risk|
|Capital at risk|
|£9.99 per month||No minimum||£7.99
|Capital at risk|
|Capital at risk|
|£36 per year||£20||£9.50
|Capital at risk|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-09-13)||-5.83%|
|1 month (2021-08-20)||-3.32%|
|3 months (2021-06-18)||0.87%|
|6 months (2021-03-19)||-5.06%|
|1 year (2020-09-18)||77.95%|
|2 years (2019-09-19)||15.20%|
|3 years (2018-09-19)||0.14%|
|5 years (2016-09-19)||3.81%|
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
Barclays's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Barclays shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Barclays's P/E ratio is best considered in relation to those of others within the banks-diversified industry or those of similar companies.
Barclays's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3032. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Barclays's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Barclays's PEG ratio in relation to those of similar companies.
|Revenue TTM||£21.2 billion|
|Operating margin TTM||35.2%|
|Gross profit TTM||£17.1 billion|
|Return on assets TTM||0.4%|
|Return on equity TTM||8.02%|
|Market capitalisation||£30.8 billion|
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Barclays.
Barclays's total ESG risk: 30.07
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Barclays's overall score of 30.07 (as at 01/01/2019) is pretty weak – landing it in it in the 62nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Barclays is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
To gain some more context, you can compare Barclays's total ESG risk score against those of similar companies.
Barclays's environmental score: 0.02/100
Barclays's environmental score of 0.02 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Barclays is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Barclays's social score: 14.24/100
Barclays's social score of 14.24 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that Barclays is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Barclays's governance score: 14.85/100
Barclays's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that Barclays is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Barclays's controversy score: 4/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Barclays scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Barclays has a damaged public profile.
Wondering how that compares? Below are the controversy scores of similar companies.
|Total ESG score||30.07|
|Total ESG percentile||62.22|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||4|
Dividend yield: 1.64% of stock value
Forward annual dividend yield: 1.64% of stock value
Dividend payout ratio: 10.95% of net profits
Barclays has recently paid out dividends equivalent to 1.64% of its share value annually.
Barclays has paid out, on average, around 10.95% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.64% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.64% return on their shares, in the form of dividend payments. In Barclays's case, that would currently equate to about 3p per share.
While Barclays's payout ratio might seem low, this can signify that the company is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 12 August 2021 (the "ex-dividend date").
Barclays's dividend yield is perhaps best considered in relation to those of similar companies.
Barclays's shares were split on a 4:1 basis on 29 April 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Barclays shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Barclays shares which in turn could have impacted Barclays's share price.
Over the last 12 months, Barclays's shares have ranged in value from as little as 88.885p up to 190.5596p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Barclays's is 1.4253. This would suggest that Barclays's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Barclays's beta into context you can compare it against those of similar companies.
Barclays is a British multinational bank and financial services company, and one of the "Big Four" British banks. It offers a large range of financial products, including personal loans, credit cards, and bank accounts, as well as mortgages and share dealing.
Originally founded in London in 1690, Barclays soon grew to be one the most powerful banks in the UK, and deployed the world's first cash machine (ATM) in 1967. It has a primary listing on the London Stock Exchange, and a secondary listing on the New York Stock Exchange.
Today, Barclays is organised into two separate divisions - Corporate, Investment Banking, Wealth and Investment Management, and Retail and Business Banking, with branches in more than 50 countries.
Ever wondered how to buy shares in Rocket Lab USA? We explain how and compare a range of providers that can give you access to many brands, including Rocket Lab USA.
Ever wondered how to buy shares in Camber Energy? We explain how and compare a range of providers that can give you access to many brands, including Camber Energy.
Ever wondered how to buy shares in Aterian? We explain how and compare a range of providers that can give you access to many brands, including Aterian.
Ever wondered how to buy shares in eFFECTOR Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including eFFECTOR Therapeutics.
Ever wondered how to buy shares in Santhera Pharmaceuticals Holding AG? We explain how and compare a range of providers that can give you access to many brands, including Santhera Pharmaceuticals Holding AG.
Ever wondered how to buy shares in Basilea Pharmaceutica? We explain how and compare a range of providers that can give you access to many brands, including Basilea Pharmaceutica.
Ever wondered how to buy shares in AB Science S.A.? We explain how and compare a range of providers that can give you access to many brands, including AB Science.
Ever wondered how to buy shares in Acacia Pharma Group? We explain how and compare a range of providers that can give you access to many brands, including Acacia Pharma Group.
Ever wondered how to buy shares in Blue Water Acquisition? We explain how and compare a range of providers that can give you access to many brands, including Blue Water Acquisition.
Learn more about Aditxt’s recent performance and where you can invest in Aditxt shares. We also run through some helpful rules of thumb for any investor.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.